Rand Wealth’s Novartis NVS Stock Holding History

Rand Wealth’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$5.21M	Buy	67,450 +5,077	+8%	+$375K	0.58%	52
2018 Q2	$4.22M	Sell	62,373 -10,421	-14%	-$719K	0.47%	59
2018 Q1	$5.27M	Buy	72,794 +233	+0.3%	+$17.7K	0.59%	50
2017 Q4	$5.46M	Buy	72,561 +2,580	+4%	+$195K	0.6%	52
2017 Q3	$5.38M	Buy	69,981 +196	+0.3%	+$14.8K	0.62%	48
2017 Q2	$5.22M	Buy	69,785 +393	+0.6%	+$27.9K	0.71%	45
2017 Q1	$4.62M	Sell	69,392 -2,950	-4%	-$197K	0.55%	53
2016 Q4	$4.72M	Buy	72,342 +843	+1%	+$54.7K	0.6%	54
2016 Q3	$5.06M	Buy	71,499 +3,484	+5%	+$254K	0.66%	51
2016 Q2	$5.03M	Buy	68,015 +7,998	+13%	+$553K	0.68%	48
2016 Q1	$3.9M	Buy	60,017 +2,736	+5%	+$186K	0.54%	60
2015 Q4	$4.42M	Buy	57,281 +2,670	+5%	+$212K	0.62%	50
2015 Q3	$4.5M	Buy	54,611 +9,407	+21%	+$837K	0.66%	50
2015 Q2	$3.98M	Buy	45,204 +616	+1%	+$56.5K	0.54%	51
2015 Q1	$3.94M	Buy	44,588 +5,544	+14%	+$492K	0.53%	51
2014 Q4	$3.38M	Buy	39,044 +1,181	+3%	+$97.9K	0.46%	62
2014 Q3	$3.19M	Sell	37,863 -1,482	-4%	-$120K	0.46%	58
2014 Q2	$3.19M	Sell	39,345 -17,053	-30%	-$1.34M	0.46%	59
2014 Q1	$4.3M	Buy	56,398 +2,779	+5%	+$203K	0.74%	36
2013 Q4	$3.86M	Buy	53,619 +1,907	+4%	+$133K	0.68%	40
2013 Q3	$3.56M	Sell	51,712 -598	-1%	-$39.6K	0.7%	41
2013 Q2	$3.31M	Buy	+52,310	New	+$3.4M	0.73%	42

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Rand Wealth's NVS Position: Q3 2018 in Review

Rand Wealth increased its Novartis (NVS) stake by 8.1% in Q3 2018, buying an estimated $375K and bringing the position to 67,450 shares worth $5.21M. The position accounts for 0.58% of the portfolio, ranked #52.

Rand Wealth first reported a position in NVS in Q2 2013 and has held it in 22 quarters since. The position peaked at $5.46M in Q4 2017. 1,028 funds tracked by Wall St. Rank hold NVS as of Q3 2018.

Rand Wealth held 67,450 shares of Novartis worth $5.21M as of Q3 2018.
Rand Wealth bought 5,077 Novartis shares in Q3 2018, an estimated $375K.
Novartis made up 0.58% of Rand Wealth's portfolio in Q3 2018, its #52 holding.
Rand Wealth first reported a position in Novartis in Q2 2013 and has held it in 22 quarters since.
Rand Wealth's Novartis position peaked at $5.46M in Q4 2017.
1,028 funds tracked by Wall St. Rank held Novartis as of Q3 2018.

Based on Rand Wealth's 13F filing for Q3 2018, filed 13 Nov 2018.